Skip to content
★ Sign in to follow
LS

Lady Susan Symonds

Chairman
Insider activity · 24 months3 buys0 salesCumulative net flow
Total declarations
7
Company
1
▲ Purchases (7 ops.)
€359k
▼ Sales (0 ops.)
—

Latest filing published 22 Dec 2025 for GSK plc, €34k.

Filing timeline

BuySale
Lady Susan Symonds

Insider track record

Disclosed buys
7
Disclosed sells
0
Signal history

Closed purchases

Market purchases
7

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

  • GSK plc 7 purchases · last 22 Dec 2025

Lady Susan Symonds: trading record in brief

Lady Susan Symonds discloses dealings in GSK plc to RNS (LSE). Over a trading history stretching from 1 February 2024 to 22 December 2025, the count stands at 7 filings.

No open-market sale appears; the market trades are 7 purchases worth €359k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2025 alone, the filings show 2 purchases and no sales.

A typical purchase (the median) is worth €38k. Clusters matter here: 7 out of 7 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 22 December 2025, the filings show an open-market purchase worth €34k in GSK plc. Filings reach the RNS (LSE) feed a median of 1 day after the trade. The legal deadline for notifying a trade is three business days (UK MAR). Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to Lady Susan Symonds

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▲
    PCA of Sir Jonathan Symonds (Non-Executive Chair)ExecutivesGSK plc
    29,873 GBP26RNS
    1,650 shares@ £18.10469.5% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:5a98a0c7-d756-450b-83e9-f26937fe1a0f-7
    Canonical exit: 22 Mar 2026 (T+90)
  • ▲
    PCA of Sir Jonathan Symonds (Non-Executive Chair)ExecutivesGSK plc
    19,379 GBP26RNS
    1,350 shares@ £14.3556.3% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:5708028-0
    Canonical exit: 18 Sept 2025 (T+90)
  • ▲
    PCA of Sir Jonathan Symonds (Non-Executive Chair)ExecutivesGSK plc
    19,726 GBP26RNS
    1,500 shares@ £13.15086.6% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:5479029-0
    Canonical exit: 20 Mar 2025 (T+90)
  • ▲
    PCA of Sir Jonathan Symonds (Non-Executive Chair)ExecutivesGSK plc
    99,646 GBP28RNS
    7,150 shares@ £13.936533.3% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:5410239
    Canonical exit: 28 Jan 2025 (T+90)
  • ▲
    PCA of Sir Jonathan Symonds (Non-Executive Chair)ExecutivesGSK plc
    32,291 GBP26RNS
    2,000 shares@ £16.145310.6% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:5235239-10
    Canonical exit: 18 Sept 2024 (T+90)
  • ▲
    PCA of Sir Jonathan Symonds (Non-Executive Chair)ExecutivesGSK plc
    48,137 GBP27RNS
    2,900 shares@ £16.598915.7% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:5116598-0
    Canonical exit: 18 Jun 2024 (T+90)
  • ▲
    PCA of Sir Jonathan Symonds (Non-Executive Chair)ExecutivesGSK plc
    54,972 GBP27RNS
    3,500 shares@ £15.706217.9% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:5053517-0
    Canonical exit: 1 May 2024 (T+90)

7 of 7 declarations